Related Experiment Videos
Heparin eyedrops to prevent posterior capsule opacification
L Mastropasqua1, L Lobefalo, M Ciancaglini
1Institute of Ophthalmology, University G. d'Annunzio, Chieti, Italy.
Journal of Cataract and Refractive Surgery
|April 1, 1997
Summary
Topical heparin eyedrops significantly reduced fibrotic posterior capsule opacification (PCO) after cataract surgery. This indicates heparin eyedrops are useful for managing patients post-extracapsular cataract extraction (ECCE).
Area of Science:
- Ophthalmology
- Surgical Outcomes
- Postoperative Care
Background:
- Posterior capsule opacification (PCO) is a common complication after cataract surgery.
- Effective management strategies are crucial to improve long-term visual outcomes.
Purpose of the Study:
- To investigate the efficacy of heparin eyedrops in preventing or reducing PCO following extracapsular cataract extraction (ECCE).
Main Methods:
- A 4-year prospective, case-controlled study involving 200 patients undergoing ECCE with intraocular lens (IOL) implantation.
- Patients were randomized to receive either topical heparin eyedrops or no eyedrops postoperatively.
- Evaluated postoperative inflammation, IOL precipitates, and PCO incidence.
Main Results:
- No significant difference in postoperative inflammation between groups.
- Significantly lower incidence of cellular precipitates on IOLs in the heparin group (P < .001).
- Heparin group showed a significantly lower incidence of Nd:YAG capsulotomy (P < .05) and fibrotic PCO (P = .02) within 24 months.
Conclusions:
- Topical heparin eyedrops demonstrated effectiveness in reducing long-term fibrotic PCO.
- Heparin eyedrops are a potentially useful adjunct in the postoperative management of ECCE patients.